Factors That Predict the Referral of Breast Cancer Patients Onto Clinical Trials by Their Surgeons and Medical Oncologists
- 13 March 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (6), 1203-1211
- https://doi.org/10.1200/jco.2000.18.6.1203
Abstract
PURPOSE: To improve understanding of physicians’ reluctance to refer patients to clinical trials. METHODS: This study was conducted in a large metropolitan region from 1993 to 1995 using a two-staged population-based sampling strategy. A total of 147 physicians discussed 245 patient cases and their own knowledge, attitudes, and practices toward clinical trials. RESULTS: Ninety-three patients (38.0%) were offered a trial, and 49 (52.7%) of them agreed to participate. Forty-five patients (18.4%) actually received their adjuvant therapy on trial. Older patients and those with a poorer prognosis were less likely to be referred. Patients who delayed their decision were more than three times as likely to participate in a trial and more than eight times as likely to participate when they were reported to be actively involved in making the decision. Generally, physicians in university settings and who had formal support from a cooperative group were more likely to refer patients to trials. More specifically, surgeons referred more patients to trials when they felt comfortable explaining trials or believed that treatment should not stray from protocol. Oncologists were less likely to make referrals if they perceived the paperwork to be onerous or entry requirements to be too stringent. Surgeons’ participation in recommending adjuvant therapy to patients resulted in more trial referrals unless they treated their patients with tamoxifen. CONCLUSION: (1) Physicians still need to overcome attitudinal and practical barriers to trial participation, (2) more support for physicians is needed, (3) surgeons may play a pivotal role in the recruitment of patients to adjuvant therapy trials, and (4) garnering patient enthusiasm for trial participation and involving them in the choice of adjuvant therapy may be key components to increasing trial enrollment.Keywords
This publication has 12 references indexed in Scilit:
- Subject Selection Biases in Clinical TrialsJournal of Clinical Psychopharmacology, 1996
- Behavioral aspects of clinical trials: An integrated framework from behavior theoryCancer, 1994
- Doctor-patient communication about breast cancer adjuvant therapy.Journal of Clinical Oncology, 1989
- ADDITIONAL EVIDENCE FOR THE ACCURACY OF BIOGRAPHICAL DATA: LONG‐TERM RETEST AND OBSERVER RATINGSPersonnel Psychology, 1986
- Physicians’ Reasons for Not Entering Eligible Patients in a Randomized Clinical Trial of Surgery for Breast CancerNew England Journal of Medicine, 1984
- Accrual of radiotherapy patients to clinical trialsCancer, 1983
- Cancer patient accessions into clinical trials A pilot investigation into some patient and physician determinants of entryAmerican Journal of Clinical Oncology, 1982
- Effects of Method of Subject Selection (Volunteer vs Random) and Treatment Variable on Motor PerformanceResearch Quarterly for Exercise and Sport, 1981
- Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial.BMJ, 1979
- A method for assessing volunteer bias and its application to a cardiovascular disease prevention progamme involving physical activity.Journal of Epidemiology and Community Health, 1978